SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-010388
Filing Date
2021-05-14
Accepted
2021-05-14 17:15:59
Documents
2
Period of Report
2021-05-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K a8-kcfoq12021.htm 8-K 31977
2 EX-10.16 a8-kexhibit1016.htm EX-10.16 36089
  Complete submission text file 0001628280-21-010388.txt   69228
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 21925992
SIC: 2834 Pharmaceutical Preparations